Left ventricular chamber function during inhaled nitric oxide in patients with dilated cardiomyopathy

Journal of Cardiovascular Pharmacology

Volumn 34, Issue 5, 1999, Pages 749-754

  Hayward, Christopher S ^a,b   Kalnins, Wally V ^a   Rogers, Peter ^c   Feneley, Michael P ^a   Macdonald, Peter S ^a   Kelly, Raymond P ^a  

^a ST VINCENT S HOSPITAL   (Australia)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^c Department of Microbiology and Infectious Diseases   (Australia)

Author keywords

Cardiomyopathy; Heart failure; Hemodynamics; Inhaled nitric oxide; Pressure volume loops

Indexed keywords

NITRIC OXIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLE; HEART DILATATION; HEART FAILURE; HEART LEFT VENTRICLE CONTRACTILITY; HEART LEFT VENTRICLE FILLING PRESSURE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE PRESSURE; HEART LEFT VENTRICLE VOLUME; HUMAN; INFERIOR CAVA VEIN OBSTRUCTION; ISCHEMIC HEART DISEASE; LUNG VASCULAR RESISTANCE; MALE; PRESSURE VOLUME CURVE; PRIORITY JOURNAL; STEADY STATE;

ADMINISTRATION, INHALATION; ADULT; AGED; BLOOD PRESSURE; CARDIOMYOPATHY, DILATED; HEART RATE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; NITRIC OXIDE; PULMONARY CIRCULATION; VASCULAR RESISTANCE; VASODILATOR AGENTS; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 0032742658     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199911000-00018     Document Type: Article

References (34)

1. Pepke-Zaba J, Higenbottam TW, Dinh-Xuan AT, Stone D, Wallwork J. Inhaled nitric oxide as a cause of selective pulmonary vasodilation in pulmonary hypertension. Lancet 1991;338:1173-4.
2. Loh E, Stamler JS, Hare JM, Loscalzo J, Colucci WS. Cardiovascular effects of inhaled nitric oxide in patients with left ventricular dysfunction. Circulation 1994;90:2780-5.
3. Semigran MJ, Cockrill BA, Kacmarek R, et al. Hemodynamic effects of inhaled nitric oxide in heart failure. J Am Coll Cardiol 1994;24:982-8.
4. Kieler-Jensen N, Rickstein S-E, Stenqvist O, et al. Inhaled nitric oxide in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance. J Heart Lung Transplant 1994;13: 366-75.
5. Hayward CS, Rogers P, Keogh AM, et al. Inhaled nitric oxide in cardiac failure: vascular versus ventricular effects. J Cardiovasc Pharmacol 1996;27:80-5.
6. Balligand J-L, Ungureanu D, Kelly RA, et al. Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium. J Clin Invest 1993;91:2314-9.
7. Hare JM, Loh E, Creager MA, Colucci WS. Nitric oxide inhibits the positive inotropic response to β-adrenergic stimulation in humans with left ventricular dysfunction. Circulation 1995;92:2198-203.
8. Finkel MS, Oddis CV, Jacob TD, et al. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 1992; 257:387-9.
9. Mohan P, Brutsaert DL, Paulus WJ, Sys SU. Myocardial contractile response to nitric oxide and cGMP. Circulation 1996;93: 1223-9.
10. Hare JM, Keaney JF, Balligand J-L, et al. Role of nitric oxide in parasympathetic modulation of beta-adrenergic myocardial contractility in normal dogs. J Clin Invest 1995;95:360-6.
11. Yamamoto S, Tsutsui H, Tagawa H, et al. Role of myocyte nitric oxide in β-adrenergic hyporesponsiveness in heart failure. Circulation 1997;95:1111-4.
12. Bocchi EA, Bacal F, Auler JOC, et al. Inhaled nitric oxide leading to pulmonary oedema in stable severe heart failure. Am J Cardiol 1994;74:70-2.
13. Argenziano M, Dean DA, Moazami N, et al. Inhaled nitric oxide is not a myocardial depressant in a porcine model of heart failure. J Thorac Cardiovasc Surg 1998;115:700-8.
14. Loh E, Lankford EB, Polidori DJ, et al. Cardiovascular effects of inhaled nitric oxide in a canine model of cardiomyopathy. Ann Thorac Surg 1999;67:1380-5.
15. Puybasset L, Rouby JJ, Mourgeon E, et al. Inhaled nitric oxide in acute respiratory failure: dose response curves. Intens Care Med 1994;20:319-27.
16. Rimar S, Gillis CN. Selective pulmonary vasodilation by inhaled nitric oxide is due to hemoglobin inactivation. Circulation 1993; 88:2884-7.
17. Hayward CS, Kalnins WV, Rogers P, et al. Effect of inhaled nitric oxide on normal left ventricular hemodynamics. J Am Coll Cardiol 1997;30:49-56.
18. Paulus WJ, Vantrimpont PJ, Shah AM. Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibility in humans: assessment by bicoronary sodium nitroprusside infusion. Circulation 1994;89:2070-8.
19. Kass DA, Midei M, Graves W, Blinker JA, Maughan WL. Use of a conductance (volume) catheter and transient inferior vena caval occlusion for rapid determination of pressure-volume relationships in man. Cathet Cardiovasc Diagn 1988;15:192-202.
20. Senzaki H, Chen C-H, Kass DA. Single beat estimation of endsystolic pressure-volume relation in humans: a new method with the potential for noninvasive application. Circulation 1996;94: 2497-506.
21. Slinker BK, Glantz SA. Multiple linear regression is a useful alternative to traditional analyses of variance. Am J Physiol 1988; 255:R353-67.
22. Paz RA, Nevo E, Pak PH, Kass DA. Sustained peri-abdominal cuff inflation: a noninvasive alternative to inferior vena caval occlusion for varying left ventricular loading [Abstract]. Circulation 1995; 92:I-203-4.
23. Michel T, Smith TW. Nitric oxide synthases and cardiovascular signalling. Am J Cardiol 1993;72:33C-8C.
24. Brady AJB, Warren JB, Poole-Wilson PA, Williams TJ, Harding SE. Nitric oxide attenuates cardiac myocyte contraction. Am J Physiol 1993;265:H176-82.
25. Mohan P, Brutsaert DL, Sys SU. Myocardial performance is modulated by interaction of cardiac endothelium derived nitric oxide and prostaglandins. Cardiovasc Res 1995;29:637-40.
26. Hare JM, Shernan SK, Body SC, et al. Influence of inhaled nitric oxide on systemic flow and ventricular filling pressure in patients receiving mechanical circulatory assistance. Circulation 1997;95: 2250-3.
27. Dickstein ML, Burkhoff D. A theoretic analysis of the effect of pulmonary vasodilation on pulmonary venous pressure: implications for inhaled nitric oxide therapy. J Heart Lung Transplant 1996;15:715-21.
28. Drexler H, Kastner S, Strobel A, et al. Expression, activity and functional significance of inducible nitric oxide synthase in the failing human heart. J Am Coll Cardiol 1998;32:955-63.
29. Ignarro LJ, Lippton H, Edwards JC, et al. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther 1981; 218:739-49.
30. Stamler JS, Jaraki O, Osborne J, et al. Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. Proc Natl Acad Sci U S A 1992;89:7674-7.
31. Jacob TD, Nakayama DK, Seki I, et al. Hemodynamic effects and metabolic fate of inhaled nitric oxide in hypoxic piglets. J Appl Physiol 1994;76:1794-801.
32. Szwarc RS, Graves CL, Flemming F, et al. Evidence for systemic effects of inhaled nitric oxide in the anesthetised minipig [Abstract]. Circulation 1995;92:I-701.
33. Young JD, Dyar O, Xiong L, Howell S. Methaemoglobin production in normal adults inhaling low concentrations of nitric oxide. Intens Care Med 1994;20:581-4.
34. Hayward CS, Kelly RP, Macdonald PS. Inhaled nitric oxide in cardiology practice. Cardiovasc Res 1999;43:628-38.